The stock of Chemours Co (NYSE:CC) reached all time high today, Nov, 30 and still has $24.70 target or 3.00% above today’s $23.98 share price. This indicates more upside for the $4.53B company. This technical setup was reported by Barchart.com. If the $24.70 PT is reached, the company will be worth $135.90M more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events. About 512,178 shares traded hands. Chemours Co (NYSE:CC) has risen 157.02% since April 27, 2016 and is uptrending. It has outperformed by 151.79% the S&P500.
Analysts await Chemours Co (NYSE:CC) to report earnings on February, 28. They expect $0.31 earnings per share, up 933.33% or $0.28 from last year’s $0.03 per share. CC’s profit will be $58.56M for 19.34 P/E if the $0.31 EPS becomes a reality. After $0.61 actual earnings per share reported by Chemours Co for the previous quarter, Wall Street now forecasts -49.18% negative EPS growth.
Chemours Co (NYSE:CC) Ratings Coverage
Out of 8 analysts covering Chemours (NYSE:CC), 3 rate it a “Buy”, 1 “Sell”, while 4 “Hold”. This means 38% are positive. Chemours has been the topic of 16 analyst reports since July 27, 2015 according to StockzIntelligence Inc. As per Tuesday, February 16, the company rating was downgraded by Jefferies. The stock of Chemours Co (NYSE:CC) has “Hold” rating given on Thursday, September 1 by Jefferies. As per Wednesday, August 10, the company rating was upgraded by Argus Research. The stock of Chemours Co (NYSE:CC) earned “Neutral” rating by Citigroup on Thursday, August 11. Citigroup initiated Chemours Co (NYSE:CC) on Friday, August 14 with “Neutral” rating. Susquehanna initiated Chemours Co (NYSE:CC) on Monday, July 27 with “Neutral” rating. The rating was upgraded by Goldman Sachs to “Buy” on Monday, March 14. The company was maintained on Monday, April 18 by Citigroup. The stock has “Neutral” rating given by JP Morgan on Friday, August 7. The stock has “Underweight” rating given by JP Morgan on Friday, August 7.
According to Zacks Investment Research, “Chemours Company is involved in chemical business. It operating segment consists of Titanium Technologies, Fluoroproducts and Chemical Solutions. Titanium Technologies segment produces titanium dioxide and premium white pigment. Fluoroproducts segment provides fluoroproducts, refrigerants and industrial fluoropolymer resins. Chemical Solutions segment provides industrial and specialty chemicals. The company’s brand consists of Teflon(R), Ti-Pure(R), Krytox(R) Viton(R), Opteon(R) and Nafion(R). Chemours Company is headquartered in Wilmington.”
More important recent Chemours Co (NYSE:CC) news were published by: Fool.com which released: “Chemours Co Surges After New Jury Verdict” on July 08, 2016, also Investorplace.com published article titled: “Trade of the Day: Chemours Co (NYSE:CC)”, Valuewalk.com published: “Chemours Co (CC) â€œMost Morally And Financially Bankrupt Companyâ€ Ever: Citron …” on June 02, 2016. More interesting news about Chemours Co (NYSE:CC) was released by: Valuewalk.com and their article: “Chemours Co (CC) Starts To Rally After Tanking On Wednesday” with publication date: July 07, 2016.
CC Company Profile
The Chemours Company, incorporated on February 18, 2014, is a well-known provider of performance chemicals. The Firm operates through three divisions: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Company’s Titanium Technologies segment produces titanium dioxide (TiO2). The Company’s Fluoroproducts segment provides fluoroproducts, such as refrigerants and industrial fluoropolymer resins. The Company’s Chemical Solutions segment provides industrial and specialty chemicals used in gold production, oil refining, agriculture, industrial polymers and other industries. The Firm operates approximately 30 production facilities located in over 10 countries and serves a range of end markets in over 130 countries.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.